ISRCTN65030272进行中（未招募）未知
Optimal prescribing of levothyroxine study (OPAL)
ewcastle upon Tyne Hospitals NHS Foundation Trust0 个研究点目标入组 130 人开始时间: 2022年10月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 130
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Patients taking levothyroxine for more than 6 months
- •2. Aged 18 years and over
- •3. No documented serum TSH =10 mU/l recorded in electronic health records
- •4. Pregnancy, breastfeeding or with a plan for pregnancy within 6 months
- •5. No history of thyroidectomy, pituitary disease or thyroid cancer
- •6. No active ischaemic heart disease, arrhythmia or other condition that in the opinion of the principal investigator would render the withdrawal of thyroid hormone unsafe
- •7. No dementia, active psychotic or serious mental health condition
- •8. Ability to give written informed consent
排除标准
- •Does not meet the inclusion criteria
研究者
相似试验
招募中
3 期
Investigating the effect of levothyroxine therapy on sex hormone levelsIRCT20181006041252N6Sabzevar University of Medical Sciences80
招募中
不适用
ew method of levothyroxine dose estimation in primary HypothyroidismCTRI/2021/07/034565Principal Investigator
尚未招募
2 期
Weekly once oral Levothyroxine replacement in subjects with Thyroxine pseudo-malabsorptioCTRI/2024/05/068083Dept of Endocrinology
招募中
3 期
Evaluation of the effect of levothyroxine in subclinical hypothyroidismIRCT20200731048259N1Shahid Beheshti University of Medical Sciences60
已完成
不适用
A randomised controlled trial of thyroxine in preterm infants under 28 weeks gestatioISRCTN89493983iverpool Women's NHS Foundation Trust (UK)150